29 research outputs found

    Genetic Disorders of Calcium and Phosphorus Metabolism Related with Parathyroid Glands

    Get PDF
    Calcium (Ca), phosphorus (phosphate, HPO4), and magnesium (Mg) are essential nutrients that are critical for the structural integrity and functions of the body. Therefore, disorders of calcium and phosphorus metabolism lead to serious and even life-threatening consequences such as skeletal and cardiovascular morbidity. Parathyroid hormone (PTH), calcitonin, and the active form of vitamin D (calcitriol, 1,25-dihydroxyvitamin D3) hormones are the main hormones that are responsible for regulating the calcium and phosphorus level in the blood. Hypoparathyroidism is due to insufficient circulating parathyroid hormone levels characterized by hypocalcemia and hyperphosphatemia. Besides being an isolated condition or a component of a complex syndrome, the causes of hypoparathyroidism are rarely genetic. Primary hyperparathyroidism is a disorder that results in excessive, uncontrolled production of parathyroid hormone. Rarely, primary hyperparathyroidism caused by genetic disorders is associated with an inherited familial germline mutation syndrome such as familial isolated hyperparathyroidism and multiple endocrine neoplasia type 1 and type 2A. Although genetic disorders are not the most common cause of hyper/hypoparathyroidism, molecular analyses have identified an increasing number of genes that cause loss or gain of function of genes related to calcium and phosphorus metabolism

    Parathyroid Disorders

    No full text

    Should Patients with Down Syndrome be Screened for Testicular Microlithiasis?

    No full text
    BackgroundTesticular microlithiasis (TM) is a rare condition characterized by asymptomatic calcification of seminiferous tubules and is considered as a precursor of testicular germ cell tumors. The prevalence of TM has been reported higher in patients with Down syndrome (DS) than general population. Our aim was to determine the prevalence of TM in our patients with DS

    Smith-Lemli-Opitz Sendromu (SLOS): Prenatal ve Postnatal Dönemde Tanısı

    No full text
    Smith-Lemli-Opitz Sendromu (SLOS), kolesterol biyosentezindeki bir enzim eksikliğinin multipl konjenital anomalilere ve mental retardasyona yol açtığı otozomal resesif geçişli doğumsal bir metabolizma hastalığıdır. Bu çalışmada kolesterol biyosentez hastalıklarından biri olan SLOS kesin tanılı iki vakanın klinik bulguları sunulmuştur. Nedeni belirlenemeyen hafif-orta mental retardasyon ve dismorfizmi olan hastalarda, basit bir laboratuvar testi olan serum kolesterol düzeyinin düşük ya da normalin alt sınırında olması ve 7-dehidrokolesterol düzeyinde artış saptanması ile bu sendromun kesin tanısının konulabileceği vurgulanmaktadır. Taşıyıcı sıklığı ile karşılaştırıldığında kesin tanı konulan hastaların az olduğu bu sendromun tanı konma yüzdesinin arttırılabileceğini ve son yıllarda önem kazanan otistik bulguları olan hafif mental retardasyonlu SLOS vakalarının da hekimler tarafından tanınması amaçlanmaktadı
    corecore